Addiction News

The rates of fatal drug overdoses stayed higher than expected in most states from 2020 to 2023 compared with trajectories before 2020, a cross-sectional analysis in JAMA Network Open showed.

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after cannabis legalization, according to a study published in JAMA Network Open.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health issues, recent data suggest they may improve brain health.

Although the prevalence of substance use disorder increased during the COVID-19 pandemic, the receipt of treatment declined before rebounding, according to a research letter published in JAMA Network Open.

The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously developed drugs, according to data in a research latter published in JAMA Network Open.

Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA Network Open.

Mortality among adults aged 25 to 44 years rose significantly between 2011 and 2023 compared with trends in the early 2000s, results from a cross-sectional study showed.

Low-dose initiation of buprenorphine in an outpatient setting showed low rates of success among a cohort of adults with opioid use disorder who self-reported daily fentanyl use, according to a study published in JAMA Network Open.

Adults aged 18 to 49 years who used cannabis for medical reasons had higher rates of cannabis use disorder compared with adults who only used cannabis recreationally, according to a research letter published in JAMA Psychiatry.